# ZAR1

## Overview
ZAR1, or zygote arrest 1, is a gene that encodes a cytosolic protein involved in critical cellular processes, particularly during oocyte maturation and early embryonic development. The ZAR1 protein plays a pivotal role in regulating the maternal transcriptome and mRNA translational activation, essential for the maternal-to-zygotic transition. It functions as a tumor suppressor, interacting with RNA-binding proteins and components of cytoplasmic lattices to control cell cycle progression and maintain genomic stability (Rong2019ZAR1; Deutschmeyer2020The). The expression of ZAR1 is notably high in reproductive and various somatic tissues, including the testis, colon, and lung, underscoring its importance in both reproductive health and cancer biology (Deutschmeyer2020The). Mutations and epigenetic alterations in ZAR1 are linked to infertility and several cancers, highlighting its clinical significance (Tian2020Variation; Deutschmeyer2020The).

## Function
The ZAR1 gene, known as zygote arrest 1, encodes a protein that plays a significant role in various cellular processes, particularly in oocyte maturation and early embryonic development. In healthy human cells, ZAR1 is involved in the regulation of the maternal transcriptome and mRNA translational activation during oocyte maturation. It interacts with RNA-binding proteins and components of cytoplasmic lattices, which are crucial for mRNA and ribosome storage during the maternal-to-zygotic transition (Rong2019ZAR1). ZAR1 is also implicated in cell cycle control, acting as a tumor suppressor by inhibiting cell cycle progression through its interaction with mRNA, such as WEE1, which negatively regulates the cell cycle (Deutschmeyer2020The).

The protein is cytosolic and exerts its tumor-suppressive properties through its C-terminal zinc finger, which is essential for binding to mRNA and associating with the ribosomal network (Deutschmeyer2020The). ZAR1's expression is highest in tissues such as the testis, colon, bone marrow, and lung, and it is also detectable in the kidney, skin, and brain (Deutschmeyer2020The). Its role in regulating mRNA translation and stability is crucial for successful fertilization and embryo progression (Uzbekova2006Zygote).

## Clinical Significance
The ZAR1 gene is clinically significant due to its involvement in various diseases and conditions related to its mutations and altered expression. In the context of cancer, ZAR1 is often hypermethylated, leading to its inactivation as a tumor suppressor gene. This hypermethylation is observed in several cancer types, including lung, kidney, melanoma, and brain cancers, and is associated with poor prognosis in conditions like neuroblastoma (Deutschmeyer2020The). In gliomas and pituitary adenomas, aberrant hypermethylation of ZAR1 is frequent, correlating with higher proliferation indices in tumors (WATANABE2010Aberrant).

In reproductive health, mutations in ZAR1 are linked to infertility issues. Specifically, ZAR1 mutations can lead to recurrent zygote arrest during in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) programs, where fertilized eggs fail to develop beyond the one-cell stage (Bai2020Genome; Tian2020Variation). Studies have identified specific single nucleotide polymorphisms (SNPs) in ZAR1 that are associated with this condition, suggesting a genetic basis for zygote arrest (Tian2020Variation). These findings highlight the gene's critical role in both cancer biology and reproductive health.


## References


[1. (Uzbekova2006Zygote) Svetlana Uzbekova, Monica Roy-Sabau, Rozenn Dalbiès-Tran, Christine Perreau, Pascal Papillier, Florence Mompart, Aurore Thelie, Sophie Pennetier, Juliette Cognie, Veronique Cadoret, Dominique Royere, Philippe Monget, and Pascal Mermillod. Zygote arrest 1 gene in pig, cattle and human: evidence of different transcript variants in male and female germ cells. Reproductive Biology and Endocrinology, March 2006. URL: http://dx.doi.org/10.1186/1477-7827-4-12, doi:10.1186/1477-7827-4-12. This article has 55 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1477-7827-4-12)

[2. (Tian2020Variation) Ye Tian, Jie Yang, Yingqian Peng, Tailai Chen, Tao Huang, Changming Zhang, and Han Zhao. Variation screening of zygote arrest 1(zar1) in women with recurrent zygote arrest during ivf/icsi programs. Reproductive Sciences, 27(12):2265–2270, July 2020. URL: http://dx.doi.org/10.1007/s43032-020-00246-y, doi:10.1007/s43032-020-00246-y. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s43032-020-00246-y)

[3. (Deutschmeyer2020The) Verena E. Deutschmeyer and Antje M. Richter. The zar1 protein in cancer; from epigenetic silencing to functional characterisation and epigenetic therapy of tumour suppressors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1874(2):188417, December 2020. URL: http://dx.doi.org/10.1016/j.bbcan.2020.188417, doi:10.1016/j.bbcan.2020.188417. This article has 6 citations.](https://doi.org/10.1016/j.bbcan.2020.188417)

[4. (WATANABE2010Aberrant) Takao WATANABE, Kazunari YACHI, Takashi OHTA, Takao FUKUSHIMA, Atsuo YOSHINO, Yoichi KATAYAMA, Yui SHINOJIMA, Tadashi TERUI, and Hiroki NAGASE. Aberrant hypermethylation of non-promoter zygote arrest 1 (zar1) in human brain tumors. Neurologia medico-chirurgica, 50(12):1062–1069, 2010. URL: http://dx.doi.org/10.2176/nmc.50.1062, doi:10.2176/nmc.50.1062. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.2176/nmc.50.1062)

[5. (Rong2019ZAR1) Yan Rong, Shu-Yan Ji, Ye-Zhang Zhu, Yun-Wen Wu, Li Shen, and Heng-Yu Fan. Zar1 and zar2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mrna translational activation. Nucleic Acids Research, 47(21):11387–11402, October 2019. URL: http://dx.doi.org/10.1093/nar/gkz863, doi:10.1093/nar/gkz863. This article has 78 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkz863)

[6. (Bai2020Genome) Dandan Bai, Jin Sun, Yanping Jia, Jiqing Yin, Yalin Zhang, Yanhe Li, Rui Gao, Xiling Du, Kunming Li, Jiaming Lin, Zhifen Tu, Yu Wang, Jiaping Pan, Shanshan Liang, Yi Guo, Jingling Ruan, Xiaochen Kou, Yanhong Zhao, Hong Wang, Cizhong Jiang, Fengchao Wang, Xiaoming Teng, Wenqiang Liu, and Shaorong Gao. Genome transfer for the prevention of female infertility caused by maternal gene mutation. Journal of Genetics and Genomics, 47(6):311–319, June 2020. URL: http://dx.doi.org/10.1016/j.jgg.2020.06.002, doi:10.1016/j.jgg.2020.06.002. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jgg.2020.06.002)